(PANW) Palo Alto Networks - Overview
Sector: TechnologyIndustry: Software - Infrastructure | Exchange NASDAQ (USA) | Currency USD | Market Cap: 125.028m | Total Return -15.7% in 12m
Stock: Firewall, Cloud-Security, SASE, XDR, AI-Security
| Risk 5d forecast | |
|---|---|
| Volatility | 42.2% |
| Relative Tail Risk | -0.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.41 |
| Alpha | -35.04 |
| Character TTM | |
|---|---|
| Beta | 1.202 |
| Beta Downside | 0.717 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.01% |
| CAGR/Max DD | 0.39 |
EPS (Earnings per Share)
Revenue
Risks
P/E ratio: 87.5543
Description: PANW Palo Alto Networks March 01, 2026
Palo Alto Networks (NASDAQ: PANW) is a global cybersecurity provider offering a broad portfolio that includes the Prisma Access SASE solution, cloud-native application protection platforms, virtual firewalls (VM-Series, CN-Series), and the Cortex suite for AI-driven security operations, threat intelligence (Unit 42), and attack surface management. Its products serve enterprises, service providers, and government agencies across industries such as financial services, healthcare, and manufacturing.
For FY 2025, PANW reported $5.5 billion in revenue, a 13% year-over-year increase driven by strong growth in subscription and SaaS offerings, with annual recurring revenue (ARR) reaching $7.2 billion. Gross margins expanded to 78%, reflecting the shift toward higher-margin cloud services. The cybersecurity sector remains a tailwind as global cyber-crime costs are projected to exceed $15 trillion by 2027, spurring accelerated cloud migration and AI-related security spending.
For a deeper dive, consider exploring ValueRay’s analyst tools to supplement your own research.
Headlines to watch out for
- Increased enterprise cybersecurity spending boosts subscription revenue
- Cloud security platform adoption expands market share
- AI-driven security solutions attract new customers
- Competitive landscape intensifies pricing pressure
- Macroeconomic slowdown impacts IT security budgets
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 1.28b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 2.29 > 1.0 |
| NWC/Revenue: 3.64% < 20% (prev -14.15%; Δ 17.78% < -1%) |
| CFO/TA 0.16 > 3% & CFO 3.97b > Net Income 1.28b |
| Net Debt (-3.79b) to EBITDA (2.20b): -1.72 < 3 |
| Current Ratio: 1.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (713.0m) vs 12m ago 0.56% < -2% |
| Gross Margin: 73.50% > 18% (prev 0.74%; Δ 7.28k% > 0.5%) |
| Asset Turnover: 43.08% > 50% (prev 40.91%; Δ 2.17% > 0%) |
| Interest Coverage Ratio: 1.56k > 6 (EBITDA TTM 2.20b / Interest Expense TTM 1.10m) |
Altman Z'' 1.65
| A: 0.01 (Total Current Assets 8.37b - Total Current Liabilities 8.01b) / Total Assets 24.98b |
| B: 0.13 (Retained Earnings 3.25b / Total Assets 24.98b) |
| C: 0.07 (EBIT TTM 1.71b / Avg Total Assets 22.97b) |
| D: 0.60 (Book Value of Equity 9.39b / Total Liabilities 15.59b) |
| Altman-Z'' Score: 1.65 = BB |
Beneish M -3.20
| DSRI: 0.81 (Receivables 2.12b/2.25b, Revenue 9.89b/8.57b) |
| GMI: 1.00 (GM 73.50% / 73.86%) |
| AQI: 0.95 (AQ_t 0.63 / AQ_t-1 0.66) |
| SGI: 1.15 (Revenue 9.89b / 8.57b) |
| TATA: -0.11 (NI 1.28b - CFO 3.97b) / TA 24.98b) |
| Beneish M-Score: -3.20 (Cap -4..+1) = AA |
What is the price of PANW shares?
Over the past week, the price has changed by -9.78%, over one month by -1.28%, over three months by -21.32% and over the past year by -15.72%.
Is PANW a buy, sell or hold?
- StrongBuy: 26
- Buy: 11
- Hold: 13
- Sell: 0
- StrongSell: 2
What are the forecasts/targets for the PANW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 207.8 | 41.3% |
| Analysts Target Price | 207.8 | 41.3% |
PANW Fundamental Data Overview March 27, 2026
P/E Forward = 44.2478
P/S = 12.6373
P/B = 14.0692
P/EG = 2.944
Revenue TTM = 9.89b USD
EBIT TTM = 1.71b USD
EBITDA TTM = 2.20b USD
Long Term Debt = 372.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = unknown (none)
Debt = 372.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -3.79b USD (from netDebt column, last quarter)
Enterprise Value = 120.86b USD (125.03b + Debt 372.0m - CCE 4.54b)
Interest Coverage Ratio = 1.56k (Ebit TTM 1.71b / Interest Expense TTM 1.10m)
EV/FCF = 29.72x (Enterprise Value 120.86b / FCF TTM 4.07b)
FCF Yield = 3.36% (FCF TTM 4.07b / Enterprise Value 120.86b)
FCF Margin = 41.10% (FCF TTM 4.07b / Revenue TTM 9.89b)
Net Margin = 12.96% (Net Income TTM 1.28b / Revenue TTM 9.89b)
Gross Margin = 73.50% ((Revenue TTM 9.89b - Cost of Revenue TTM 2.62b) / Revenue TTM)
Gross Margin QoQ = 73.59% (prev 74.21%)
Tobins Q-Ratio = 4.84 (Enterprise Value 120.86b / Total Assets 24.98b)
Interest Expense / Debt = 0.30% (Interest Expense 1.10m / Debt 372.0m)
Taxrate = 21.31% (117.0m / 549.0m)
NOPAT = 1.35b (EBIT 1.71b * (1 - 21.31%))
Current Ratio = 1.04 (Total Current Assets 8.37b / Total Current Liabilities 8.01b)
Debt / Equity = 0.04 (Debt 372.0m / totalStockholderEquity, last quarter 9.39b)
Debt / EBITDA = -1.72 (Net Debt -3.79b / EBITDA 2.20b)
Debt / FCF = -0.93 (Net Debt -3.79b / FCF TTM 4.07b)
Total Stockholder Equity = 8.28b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.58% (Net Income 1.28b / Total Assets 24.98b)
RoE = 15.49% (Net Income TTM 1.28b / Total Stockholder Equity 8.28b)
RoCE = 19.82% (EBIT 1.71b / Capital Employed (Equity 8.28b + L.T.Debt 372.0m))
RoIC = 16.11% (NOPAT 1.35b / Invested Capital 8.37b)
WACC = 10.18% (E(125.03b)/V(125.40b) * Re(10.21%) + D(372.0m)/V(125.40b) * Rd(0.30%) * (1-Tc(0.21)))
Discount Rate = 10.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.28%
[DCF] Terminal Value 73.99% ; FCFF base≈3.61b ; Y1≈4.25b ; Y5≈6.51b
[DCF] Fair Price = 100.5 (EV 77.70b - Net Debt -3.79b = Equity 81.49b / Shares 811.0m; r=10.18% [WACC]; 5y FCF grow 18.84% → 3.0% )
EPS Correlation: 77.90 | EPS CAGR: 38.95% | SUE: 3.89 | # QB: 4
Revenue Correlation: 98.20 | Revenue CAGR: 18.18% | SUE: 1.13 | # QB: 3
EPS next Quarter (2026-04-30): EPS=0.80 | Chg7d=+0.000 | Chg30d=-0.124 | Revisions Net=-39 | Analysts=43
EPS current Year (2026-07-31): EPS=3.69 | Chg7d=+0.000 | Chg30d=-0.160 | Revisions Net=-41 | Growth EPS=+10.5% | Growth Revenue=+22.5%
EPS next Year (2027-07-31): EPS=2.29 | Chg7d=+0.000 | Chg30d=-0.085 | Revisions Net=-1 | Growth EPS=+16.7% | Growth Revenue=+20.2%
[Analyst] Revisions Ratio: -0.95 (1 Up / 40 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.1% (Discount Rate 10.2% - Earnings Yield 1.1%)
[Growth] Growth Spread = +19.6% (Analyst 28.6% - Implied 9.1%)